WIPR takes a look at what IP practitioners and commentators have said are some of the most influential court cases to have been decided over the last 12 months.
Association for Molecular Pathology et al v US Patent and Trademark Office et al
In a case widely-tipped to be heard by the US Supreme Court, the US Court of Appeals for the Federal Circuit held that DNA inventions could be patented.
The American Civil Liberties Union wanted pharmaceutical company Myriad Genetics’ patents for the BRCA1 and BRCA2 breast cancer genes to be invalidated because, it argued, they were incorrectly granted in terms of composition and method.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
2011, court decisions
